Most Viewed Articles
| Articles | Fulltext downloads | PDF downloads |
|---|---|---|
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text |  PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI:10.25259/IJMIO_30_2020 |
8,956 | 1,074 |
EditorialNanobytesFull text | PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI:10.25259/IJMIO_7_2019 |
4,767 | 4,029 |
Review ArticleThe evolving role of precision medicine in the management of advanced sarcomas – A mini reviewFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_6_2021 |
8,575 | 75 |
New Drug UpdateAmlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitorFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_13_2021 |
8,470 | 75 |
Case ReportHyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young maleFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_16_2021 |
8,468 | 62 |
Brief CommentaryERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginningFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_10_2021 |
8,148 | 39 |
Review ArticleImmuno-oncology of differentiated thyroid cancerFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI:10.25259/IJMIO_36_2020 |
7,142 | 1,001 |
Review ArticlePost-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspectiveFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_12_2021 |
7,889 | 77 |
Review ArticleA compendium of population wide DNA methylation profile for oral cancer in IndiaFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI:10.25259/IJMIO_2_2021 |
6,879 | 1,079 |
Brief CommentaryBioactive lipid: A novel diagnostic approach for retinoblastoma in clinical managementFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_7_2021 |
6,921 | 210 |
EditorialMisleading and Biased Lancet Editorial on Kashmir: What are the Authors Hiding?Full text | PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI:10.25259/IJMIO_8_2019 |
3,143 | 3,880 |
Original ArticleReal World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in IndiaFull text | PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI:10.25259/IJMIO_1_2019 |
3,157 | 3,426 |
Original ArticleAdvanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation regionFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI:10.25259/IJMIO_15_2021 |
5,684 | 689 |
Position PaperPractical consensus recommendations – Current role of immune response evaluation criteria in solid tumors criteria in the management of cancer patients receiving immunotherapyFull text | PDF Year: 2019, Volume: 4, Issue: 1, January-April DOI:10.25259/IJMIO-6-2019 |
3,741 | 2,485 |
Original ArticleIndian Surgeons’ Perspective Regarding Breast-Conserving Surgery: A Cohort StudyFull text | PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI:10.25259/IJMIO_15_2019 |
2,884 | 3,254 |
Short CommunicationDriver mutations in oncogenesisFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI:10.25259/IJMIO_26_2020 |
5,640 | 460 |
NewsEditorial board tribute to Dr. Amit VermaFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December |
5,957 | 52 |
Brief CommentaryMyths in oncologyFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI:10.25259/IJMIO_37_2020 |
4,825 | 1,117 |
EditorialNanobytesFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI:10.25259/IJMIO_11_2021 |
5,265 | 667 |
Case ReportMetastatic endometrial carcinoma responsive to pembrolizumabFull text | PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI:10.25259/IJMIO_18_2020 |
4,058 | 1,865 |
Conference Review6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapiesFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_20_2021 |
5,823 | 57 |
EditorialImmune checkpoint inhibitor – antiangiogenic drugs combination in treatment-naïve metastatic clear cell renal cell carcinoma: Why should immunotherapy have all the fun!Full text | PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI:10.25259/IJMIO_23_2019 |
3,120 | 2,732 |
Original ArticleMultiple gene silencing in pathway in K562 cellsFull text | PDF Year: 2019, Volume: 4, Issue: 1, January-April DOI:10.25259/IJMIO-5-2019 |
3,441 | 2,392 |
Case ReportComplete metabolic response with letrozole and palbociclib in advanced breast cancerFull text | PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI:10.25259/IJMIO_2_2019 |
3,515 | 2,250 |
Review ArticleImpact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent hybridization and Immunohistochemistry: A meta-analysis with systematic reviewFull text | PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI:10.25259/IJMIO_17_2019 |
2,866 | 2,645 |
